Josh Mandel-Brehm, CEO, Director at CAMP4 Therapeutics Corporation, holds 284.97K shares in CAMP4 Therapeutics Corporation (Ticker: CAMP), holds ― shares in ProMIS Neurosciences (Ticker: PMN). Most recently, Josh Mandel-Brehm Bought ― shares of CAMP4 Therapeutics Corporation on Aug 05, 2026 for an estimated value of $10.81K.
What is the percentage of profitable transactions made by Josh Mandel-Brehm?
The percentage of profitable transactions made by Josh Mandel-Brehm is 100%.
What is the average return per transaction made by Josh Mandel-Brehm?
The average return per transaction made by Josh Mandel-Brehm is 34.20%.
What stocks does Josh Mandel-Brehm hold?
Josh Mandel-Brehm holds: CAMP, PMN stocks.
What was Josh Mandel-Brehm’s latest transaction?
Josh Mandel-Brehm latest transaction was an Informative Buy of $10.81K.
What was Josh Mandel-Brehm's most profitable transaction?
Josh Mandel-Brehm’s most profitable transaction was an Informative Buy of CAMP stock on September 11, 2025. The return on the trade was 58.60%.
What is Josh Mandel-Brehm's role in CAMP4 Therapeutics Corporation?
Josh Mandel-Brehm's role in CAMP4 Therapeutics Corporation is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.